本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VITASORA HEALTH LIMITED

0.014
0.000
成交量:94.22萬
成交額:1.32萬
市值:3,275.48萬
市盈率:-2.00
高:0.014
開:0.014
低:0.014
收:0.014
52周最高:0.039
52周最低:0.009
股本:23.40億
流通股本:13.59億
量比:0.95
換手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-0.007
每股收益(LYR):-0.007
淨資產收益率:-106.25%
總資產收益率:-53.62%
市淨率:1.93
市盈率(LYR):-1.93

資料載入中...

公司資料

公司名字:
VITASORA HEALTH LIMITED
交易所:
ASX
成立時間:
- -
員工人數:
30
公司地址:
432 St Kilda Road,Suite 1, Level 9,Melbourne,Victoria,Australia
郵編:
3004
傳真:
61 3 9822 7735
簡介:
Respiri Limited, a health technology company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; Wholter, a device for home ambulatory recording of nocturnal wheeze and cough; and AirSonea, a digital stethoscope that is paired to a smartphone app to record breathing sounds accurately. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs; and SonoSentry, an over-the-counter wheeze-detection device. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited was incorporated in 1987 and is based in Melbourne, Australia.